Recovery of Parainfluenza Viruses From Adults With Upper Respiratory Illness

Bloom, Henry H.; Johnson, K. M.; Jacobsen, Ramunė; Chanock, R. M.

doi:10.1093/oxfordjournals.aje.a120200

Cited by 28 publications

(25 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…HPIV-3 has been implicated in supraglottitis and bronchiolitis obliterans (120,285). HPIV parotitis has been diagnosed in otherwise healthy children infected with HPIV-1 and HPIV-3 (26,402), in immunocompromised children (381), and in a patient with cystic fibrosis (34). Croup caused by HPIV has been associated with bacterial tracheitis (83,218).…”

Section: Clinical Syndromesmentioning

confidence: 99%

Parainfluenza Viruses

2003

View full text Add to dashboard Cite

Human parainfluenza viruses (HPIV) were first discovered in the late 1950s. Over the last decade, considerable knowledge about their molecular structure and function has been accumulated. This has led to significant changes in both the nomenclature and taxonomic relationships of these viruses. HPIV is genetically and antigenically divided into types 1 to 4. Further major subtypes of HPIV-4 (A and B) and subgroups/genotypes of HPIV-1 and HPIV-3 have been described. HPIV-1 to HPIV-3 are major causes of lower respiratory infections in infants, young children, the immunocompromised, the chronically ill, and the elderly. Each subtype can cause somewhat unique clinical diseases in different hosts. HPIV are enveloped and of medium size (150 to 250 nm), and their RNA genome is in the negative sense. These viruses belong to the Paramyxoviridae family, one of the largest and most rapidly growing groups of viruses causing significant human and veterinary disease. HPIV are closely related to recently discovered megamyxoviruses (Hendra and Nipah viruses) and metapneumovirus

show abstract

Section: Clinical Syndromesmentioning

confidence: 99%

Parainfluenza Viruses

2003

View full text Add to dashboard Cite

show abstract

“…Moreover, reinfection after a primary infection with HPIV3 is a common occurrence (1,6). In one study the frequency of HPIV3 reinfection was found to be 58% in 1-year-old children and 34% in 2-year-old children (1).…”

Section: Introductionmentioning

confidence: 99%

Infection and immunoregulation of T lymphocytes by parainfluenza virus type 3.

Sieg¹,

Muro-Cacho²,

Robertson³

et al. 1994

Proc. Natl. Acad. Sci. U.S.A.

View full text Add to dashboard Cite

Human paanfluenza virus type 3 (HPIV3) is a major cause of dise In newborns and Infants. It also has a king potential to reinfect individuals throughout their lives, suggesting that HPIV3 does not induce lifelong immunity; however, the operative mechanism for the failure to prevent reinfection is not known. We have as d the potential of the virus to infect nontransformed human Tlymphocytes and have found that T cells are readily infected by the virus. Productive infection requires activation of the T cells and results in a marked inhibition of proliferation. Furthermore, our results indicate that exposure to the virus, even without overt expression of viral proteins as det by imunohistol, profoundly alters the functional capacity of the T cells. The capacity of the virus to regulate T-lymphocyte function may play an important role In the failure of the virus to induce lifelong immunity.Human parainfluenza virus type 3 (HPIV3) causes severe respiratory tract infections in infants and children (1-5) and upper respiratory tract infections in adults (6-8). It is efficiently spread from person-to-person (5, 6); consequently, all adults possess anti-HPIV3 immunoglobulins (6).Persistent infection of the virus has been documented in various clinical situations (8-10). Moreover, reinfection after a primary infection with HPIV3 is a common occurrence (1,6). In one study the frequency of HPIV3 reinfection was found to be 58% in 1-year-old children and 34% in 2-year-old children (1). Even in the presence of circulating neutralizing antibodies, adults have been shown to be susceptible to reinfection (6). This clinical characteristic is distinct from infection with either measles or mumps viruses, which result in lifelong immunity against reinfection. It appears that infection with HPIV3 does not result in the establishment of a state of long-lasting immunity (11).The mechanisms for persistent infection or for reinfection with HPIV3 have not been determined; however, it is likely that the equilibrium between the human host and the viral parasite arises as a result ofthe complex interactions between the host's immune system and the virus. One significant aspect of this interaction is infection of T lymphocytes by viruses. Viral infection of T lymphocytes has been demonstrated for many different viruses and has been shown to profoundly alter the immune response (12-15). Although T cells have the potential to lyse virally infected cells, help B lymphocytes produce immunoglobulins, and establish longlived memory cells, the possibility that HPIV3-mediated immunoregulation of T lymphocytes plays a role in either persistence or reinfection has not been considered.In this report we demonstrate that HPIV3 has a marked immunoregulatory effect on human T lymphocytes even in the absence of productive infection as detected by immunohistology. Experiments were also performed by infecting the PBMC with HPIV3 without washing out the virus. The results from these experiments were similar to the results from experiments that were perfo...

show abstract

“…Similar to infections with other paramyxoviruses such as respiratory syncytial virus (RSV), nearly all children have been infected with PIV-3 by age 3 to 5 (Clyde & Denny, 1983). Reinfection of older children and adults is common (Bloom et al, 1961). A safe and effective vaccine does not currently exist for control of PIV-3 infection.…”

Section: Introductionmentioning

confidence: 99%